Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Presentation Fellows 2021

Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS): What You Need to Know

Presenter: Celina M. Yong

May 09, 2021

Presentation Fellows 2019

State of the art treatment In NSTE-ACS: Management Strategies

Presenter: Sunil V. Rao

April 12, 2019

Presentation TCT Abstracts Posters 2018

Syntax score as predictor of one-year mortality in patients with NSTE-ACS

Presenter: F. Boukerche

September 25, 2018

Presentation

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

August 14, 2017

Presentation

Early Invasive vs Selective Strategy for NSTE ACS

April 11, 2017

Presentation

Spontaneous MI After NSTE ACS Managed Without Revascularization

Presenter: Renato Lopes

March 15, 2016

Presentation

Does Stable NSTE-ACS Require Admission to Coronary Care Units?

Presenter: S. van Diepen

January 27, 2016

Presentation

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Presenter: Tobias Geisler

September 18, 2015

Presentation

RITA 3: 10-Year Mortality Outcome of Routine Invasive vs Selective Invasive Strategy in NSTE-ACS

Presenter: Robert A. Henderson

July 29, 2015

Presentation

Effect of an Invasive Strategy on Outcome in Patients ≥ 75 Years of Age With NSTE-ACS

Presenter: Gennaro Galasso

January 11, 2015

Presentation AHA 2014

Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery

Presenter: S. van Diepen

November 16, 2014

Presentation TCT 2014

Role of Intravascular Imaging in NSTE-ACS and STEMI

Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Fernando Alfonso

September 16, 2014

Presentation TCT 2014

NSTE-ACS: Risk Stratification and Treatment

Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman

September 13, 2014

Presentation TCT 2014

Case #1: NSTE-ACS Caused by Neoatherosclerosis in Saphenous Bypass Grafts: Insights from OCT

Presenter: Dan Deleanu, Dariusz Dudek, Robert J. Gil, Greg L. Kaluza, Andrzej J. Ochala, Wojtek Wojakowski

September 13, 2014

Presentation

Impact of an Invasive Strategy on 5-Year Outcomes in Men and Women With NSTE-ACS

Presenter: Joakim Alfredsson

July 25, 2014

Presentation

SYNTAX Score and the Risk of Stent Thrombosis After PCI in Patients with NSTE-ACS

Presenter: M. Yadav

July 08, 2014

Presentation

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Presenter: D. Lindholm

April 25, 2014

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Presentation

Weekend vs. Weekday Presentation Does Not Affect NSTE ACS Patient Outcomes

Presenter: D. E. O?Neill

October 18, 2013

Presentation

Routine Early Eptifibatide vs. Delayed Provisional Use at PCI in High-Risk NSTE-ACS Patients

Presenter: A. Bagai

August 06, 2013

Advertisement

Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS): What You Need to Know

State of the art treatment In NSTE-ACS: Management Strategies

Syntax score as predictor of one-year mortality in patients with NSTE-ACS

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

Early Invasive vs Selective Strategy for NSTE ACS

Spontaneous MI After NSTE ACS Managed Without Revascularization

Does Stable NSTE-ACS Require Admission to Coronary Care Units?

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

RITA 3: 10-Year Mortality Outcome of Routine Invasive vs Selective Invasive Strategy in NSTE-ACS

Effect of an Invasive Strategy on Outcome in Patients ≥ 75 Years of Age With NSTE-ACS

Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery

Role of Intravascular Imaging in NSTE-ACS and STEMI

NSTE-ACS: Risk Stratification and Treatment

Case #1: NSTE-ACS Caused by Neoatherosclerosis in Saphenous Bypass Grafts: Insights from OCT

Impact of an Invasive Strategy on 5-Year Outcomes in Men and Women With NSTE-ACS

SYNTAX Score and the Risk of Stent Thrombosis After PCI in Patients with NSTE-ACS

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Weekend vs. Weekday Presentation Does Not Affect NSTE ACS Patient Outcomes

Routine Early Eptifibatide vs. Delayed Provisional Use at PCI in High-Risk NSTE-ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content